Buprenorphine Hydrochloride Market
Buprenorphine Hydrochloride Market Global Industry Assessment & Forecast
Segments Covered
- By Type Tablets, Injection
- By Application Analgesic, Opioid Antagonist
Snapshot
Forecast Years: | 2021 - 2028 |
Historical Years: | 2016 - 2020 |
Revenue 2021: | 5.05 Billion |
Revenue 2028: | 9.49 Billion |
Revenue CAGR (2021 - 2028): | 8.2 |
Fastest Growing Region (2022 - 2028) | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
The report delivers an acute breakdown of the
market based on various segments such as Type, Application,
and Region. All the segments are studied considering historical and future
trends across geographies. All the segments are analyzed based on trends,
market size, and forecast, and the data is provided for the years 2016–2028.
Several growth factors and opportunities impacting various segments have been
incorporated in the report. On the basis of Type,
the market is divided into Tablets, Injection. Tablets held the largest
share in 2020 and is projected to grow at a noteworthy CAGR within the forecast
period.
Based on Application,
the market is divided into Analgesic, Opioid Antagonist. Analgesic attributed to
the highest market share and is expected to grow at a significant CAGR from
2021 to 2028.
Global Buprenorphine Hydrochloride Market: Type Segment Analysis
-
- Tablets
- Injection
Global Buprenorphine Hydrochloride Market: Application Segment Analysis
-
- Analgesic
- Opioid Antagonist
FAQ
Frequently Asked Question
What is the global demand for Buprenorphine Hydrochloride in terms of revenue?
-
The global Buprenorphine Hydrochloride valued at 5.05 Billion in 2020 and is expected to reach 9.49 Billion in 2028 growing at a CAGR of 8.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Resonance-labs, UnichemlabsNoramco, Siegfried, Faranshimi, Johnson Matthey, Rusan Pharma, Mallinckrodt, Sanofi, Sun Pharma, Mocind, Sinopharm, Arevipharma..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.2% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Buprenorphine Hydrochloride include
- The increasing opioid addiction cases are driving the growth of the buprenorphine hydrochloride market within estimated timeframe. With this, the number of reported cases of opioid addiction is increasing due to the high availability and low cost of opioids that is also likely to support the growth of the market.
- The increasing innovations and development by government in healthcare sector is expected to hinder the growth of the market in the years to come.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Buprenorphine Hydrochloride in 2020.